Related Experiment Video
Updated: Jul 7, 2025
00:10
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.6K
Dual-Antigen Subunit Vaccine Nanoparticles for Scrub Typhus
Jaeyoung Park1, Zhiwen Zhang2,3, Tatyana Belinskaya2,3
1School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 950 Atlantic Dr. NW, Atlanta, GA 30332, USA.
Pathogens (Basel, Switzerland)
|December 22, 2023
Summary
Researchers developed novel dual-antigen nanoparticles to combat scrub typhus, a chigger-borne illness. These nanoparticles show promise as a potential vaccine against Orientia tsutsugamushi, enhancing immune responses in mice.
Area of Science:
- Vaccinology
- Bacteriology
- Nanotechnology
Background:
- Scrub typhus is an acute febrile illness caused by Orientia tsutsugamushi, prevalent in the Asia-Pacific region.
- Transmission occurs through chigger bites, and no vaccine is currently available.
- Outer membrane antigens (47 kDa and 56 kDa) of O. tsutsugamushi are immunogenic targets.
Purpose of the Study:
- To develop and evaluate dual-antigen subunit vaccine nanoparticles for O. tsutsugamushi.
- To assess the immunogenicity of these nanoparticles in a mouse model.
- To explore nanoparticle-based strategies for scrub typhus vaccine development.
Main Methods:
- Development of dual-antigen vaccine nanoparticles using recombinant 47 kDa and 56 kDa O. tsutsugamushi proteins.
- Formation via desolvation, additional coating with the 56 kDa protein, and stabilization with DTSSP and SDAD crosslinkers.
- Evaluation of antigen-specific antibody and cellular immune responses in vaccinated mice.
Main Results:
- Dual-antigen subunit vaccine nanoparticles significantly enhanced antigen-specific antibody responses compared to soluble antigens.
- Nanoparticles coated with an additional 56 kDa protein layer showed markedly superior immunogenicity in cellular immune responses.
- These results indicate potent immunogenicity of the developed dual-layered antigen nanoparticles.
Conclusions:
- Dual-layered antigen nanoparticles demonstrate potent immunogenicity and are a promising strategy for scrub typhus vaccine development.
- The enhanced cellular immune responses suggest a viable pathway for protection against O. tsutsugamushi.
- This nanoparticle-based approach offers a novel strategy to address the unmet need for a scrub typhus vaccine.
